HTA - NIHR128490

PERsonalised Medicine for Intensification of Treatment (PERMIT): the case of type 2 Diabetes Mellitus

Project title: PERsonalised Medicine for Intensification of Treatment (PERMIT): the case of type 2 Diabetes Mellitus

Call to action: 18/80 18/80 HTA Precision Medicine

Research type: Primary Research

Chief investigator: Professor Richard Grieve

Contractor: London School of Hygiene & Tropical Medicine

Cost: £547,546.04

Co-investigators: Associate Professor Stephen O'Neill, Dr Richard Silverwood, Mr Paul Charlton, Professor Amanda Adler, Professor Andrew Briggs, Professor Anirban Basu, Professor Ian Douglas, Professor Kamlesh Khunti, Professor Liam Smeeth.

Started: January 2020 | Status: Research in progress

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.